-
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Stud
Author: Jiang, Nan; Zhang, Wen; Peng, Zhenwei; Liu, Chang; Xiao, Yu-Dong; Yang, Wei-Zhu; Ding, Rong; Yin, Li-Nan; Jiang, Jian-Qiang; Ni, Cai-Fang; Yan, Zhi-Ping; Kuang, Ming; Teng, Gao-Jun; Zhong, Bin-Yan
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550734
-
Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults with Unresectable Hepatocellular Carcinoma: Post Hoc Analyses of the CARES-310 Open-Label, Randomized, Phase 3 Tria
Author: Chan, Stephen Lam; Kaseb, Ahmed Omar; Alexander, Laura; Meng, Xianzhang; Ryan, Kristin; Shi, Wei; Vogel, Arndt
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000551156
-
Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort Stud
Author: Lin, Xiaohan; Zhang, Shiying; Ong, Meiching; Fang, Jun; Mu, Aibo; Wang, Kui; Xu, Li; Bi, Xinyu; Liu, Xiufeng; Chen, Yongjun; Sun, Huichuan; Ling, Qi
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550356
-
Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysi
Author: Xie, Wenbo; Sun, Linmao; Fu, Yumin; Liang, Shuhang; Liu, Yao; Wang, Jiabei; Liu, Lianxin
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550938
-
Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World Stud
Author: Xiao, Rui; Yang, Zhenyun; Zheng, Zehao; Liu, Na; Yu, Wei; Lin, Qingyang; Chen, Jinbin; Wang, Juncheng; Zhou, Zhongguo; Zhang, Yaojun; Chen, Minshan; Hu, Dandan
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550954
-
Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinom
Author: He, Tian; Xu, Bin; Yang, Zi-Yue; Zhou, Shi-Qi; Wang, Zi-Yi; Wang, Lu-Na; Zhong, Cheng-Jie; Shi, Huan-Chen; Li, Hui; Hu, Bo; Zhu, Xiao-Dong; Shen, Ying-Hao; Gao, Qiang; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng
Journal: LIVER CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1159/000550497
-
Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Stud
Author: Pan, Zhaolong; Liu, Dongming; Cao, Junbo; Fu, Linlin; Zhang, Xihao; Zhu, Xiaodong; Pan, Yangxun; Liu, Jianwei; Han, Chuangye; Jin, Renan; Shen, Shunli; Zhang, Xiaoyun; Liu, Hongzhi; Yang, Xiaobo; Hu, Kuan; Shi, Xiaoyi; Wang, Dongxu; Zhao, Yang; Zhong, Jianhong; Xiang, Bangde; Gu, Shanzhi; Li, Tao; Zhang, Shuijun; Zhou, Ledu; Zhao, Haitao; Zeng, Yongyi; Wen, Tianfu; Kuang, Ming; Liang, Xiao; Peng, Tao; Wang, Kui; Xu, Li; Li, Huikai; Song, Tianqiang; Sun, Huichuan; Zhang, Wei
Journal: LIVER CANCER. 2025; Vol. , Issue , pp. -. DOI: 10.1159/000545545
-
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Stud
Author: Yang, Da-Long; Peng, Ning; Nong, Jun-Liang; Chen, Kang; Su, Ze; Yu, Ya-Qun; Ye, Lin; Zeng, Fan-Jian; Liu, Shao-Ping; Yan, Yi-He; Wang, Xue-Yao; Yao, Hong-Bing; Yang, Fu-Quan; Li, Wen-Feng; Qin, Chuang; Wu, Ming-Song; Yang, Yong-Yu; Dong, Xiao-Feng; Li, Mian-Jing; Liu, Jie; Liang, Yong-Rong; Wu, Pei-Sheng; Zhong, Teng-Meng; Lai, Yong-Cheng; Chen, Yao-Zhi; Pang, Qing-Qing; Wang, Guo-Dong; Li, Fu-Xin; Mao, Xian-Shuang; Chen, Shu-Chang; Ou, Jun-Jie; Huo, Rong-Rui; Liang, Xiu-Mei; Xiang, Bang-De; Ma, Liang; Zhong, Jian-Hong
Journal: LIVER CANCER. 2025; Vol. , Issue , pp. -. DOI: 10.1159/000546052
